Clinical Report: Surgical Site Infections—Epidemiology, Risk, and Management
Overview
Surgical site infections (SSIs) are a significant cause of postoperative morbidity and mortality, representing the third most common nosocomial infection in European hospitals. Early identification of risk factors and adherence to evidence-based perioperative preventive measures, including appropriate antimicrobial prophylaxis, are critical to reducing SSI incidence and improving patient outcomes.
Background
SSIs are infections occurring within 30 days post-surgery or up to one year if prosthetic material is implanted, presenting with symptoms such as purulent drainage, erythema, or abscess formation. They are classified by tissue depth and are associated with increased mortality, prolonged hospitalization, and higher healthcare costs. Risk factors are multifactorial, encompassing patient, procedural, and environmental elements, and scoring systems like the NNIS risk index help estimate SSI risk. Understanding the microbiology and implementing targeted prevention strategies are essential for effective management.
SSIs occur within 30 days postoperatively or up to one year if prosthetic material is implanted, with clinical signs including purulent drainage and wound dehiscence.
SSIs are the third most common nosocomial infection in Europe, with incidence up to 16.1%, and significantly increase postoperative mortality and healthcare costs.
The NNIS risk index is widely used to estimate SSI risk, with laparoscopic surgery reducing risk by one point.
Antimicrobial prophylaxis is recommended primarily for clean-contaminated and contaminated surgeries, with timing critical—antibiotics should be administered within 30–60 minutes before incision.
Choice of prophylactic antibiotic depends on surgical site flora, local resistance patterns, and patient factors; intravenous administration is preferred for optimal tissue levels.
Surveillance programs and adherence to guidelines are essential to optimize antibiotic use and prevent resistance and adverse effects.
Clinical Implications
Clinicians should utilize risk assessment tools like the NNIS index to identify patients at higher risk for SSIs and implement timely, evidence-based prophylactic antibiotic regimens tailored to the surgical site and local microbiology. Strict adherence to perioperative preventive measures and ongoing surveillance of antibiotic use are vital to minimize infection rates and combat antimicrobial resistance.
Conclusion
Surgical site infections remain a prevalent and serious complication of surgery, but their incidence can be significantly reduced through comprehensive risk assessment, targeted antimicrobial prophylaxis, and adherence to established preventive protocols. Continuous monitoring and adaptation of strategies based on local data are essential for optimal patient outcomes.
